VREOF
Vireo Growth Inc.
OTC Pharmaceutical Preparations
Emerging growth company

Key Financials

Net Income
$-68113908
↓ 143.2%
Revenue
$268.8M
↑ 170.4%
Operating Income
$-1048483
↓ 107.7%
Gross Profit
$127.1M
↑ 150.3%
Total Liabilities
$509.7M
↑ 128.3%
EPS (Diluted)
$-0.09
↑ 43.8%
Total Assets
$817.2M
↑ 193.0%
Shareholders' Equity
$307.4M
↑ 453.3%

Recent SEC Filings

Form Type Filed Date Link
D 6/29/2026 View on SEC
D 6/22/2026 View on SEC
8-K/A 6/18/2026 View on SEC
8-K 6/18/2026 View on SEC
8-K/A 6/11/2026 View on SEC
8-K 6/11/2026 View on SEC
8-K 6/11/2026 View on SEC
8-K 6/9/2026 View on SEC
3 6/8/2026 View on SEC
8-K 6/3/2026 View on SEC

Company Information

Field Value
Ticker VREOF
Company Name Vireo Growth Inc.
CIK 1771706
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation A1
Phone 604-617-5421